Matthew Frampton

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Genetic analysis of four consanguineous multiplex families with inflammatory bowel disease.

Genetic analysis of four consanguineous multiplex families with inflammatory bowel disease.

Journal: Gastroenterology report

Published: October 08, 2020

Elevation in Cell Cycle and Protein Metabolism Gene Transcription in Inactive Colonic Tissue From Icelandic Patients With Ulcerative Colitis.

Elevation in Cell Cycle and Protein Metabolism Gene Transcription in Inactive Colonic Tissue From Icelandic Patients With Ulcerative Colitis.

Journal: Inflammatory bowel diseases

Published: July 09, 2018

A New Look at Familial Risk of Inflammatory Bowel Disease in the Ashkenazi Jewish Population.

A New Look at Familial Risk of Inflammatory Bowel Disease in the Ashkenazi Jewish Population.

Journal: Digestive diseases and sciences

Published: May 04, 2018

Rare coding variant analysis in a large cohort of Ashkenazi Jewish families with inflammatory bowel disease.

Rare coding variant analysis in a large cohort of Ashkenazi Jewish families with inflammatory bowel disease.

Journal: Human genetics

Published: April 03, 2018

Investigating the feasibility of tumour molecular profiling in gastrointestinal malignancies in routine clinical practice.

Investigating the feasibility of tumour molecular profiling in gastrointestinal malignancies in routine clinical practice.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: January 24, 2018

Correspondence: SEMA4A variation and risk of colorectal cancer.

Correspondence: SEMA4A variation and risk of colorectal cancer.

Journal: Nature communications

Published: March 11, 2016

Modeling the prevention of colorectal cancer from the combined impact of host and behavioral risk factors.

Modeling the prevention of colorectal cancer from the combined impact of host and behavioral risk factors.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: February 11, 2016

Rare disruptive mutations and their contribution to the heritable risk of colorectal cancer.

Rare disruptive mutations and their contribution to the heritable risk of colorectal cancer.

Journal: Nature communications

Published: January 21, 2016

Genetic diagnosis of high-penetrance susceptibility for colorectal cancer (CRC) is achievable for a high proportion of familial CRC by exome sequencing.

Genetic diagnosis of high-penetrance susceptibility for colorectal cancer (CRC) is achievable for a high proportion of familial CRC by exome sequencing.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: January 07, 2015

Common variation at 1q24.1 (ALDH9A1) is a potential risk factor for renal cancer.

Common variation at 1q24.1 (ALDH9A1) is a potential risk factor for renal cancer.

Journal: PloS one

Published: November 26, 2014

Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma.

Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma.

Journal: Nature communications

Published: May 07, 2013

Common variation at 2q22.3 (ZEB2) influences the risk of renal cancer.

Common variation at 2q22.3 (ZEB2) influences the risk of renal cancer.

Journal: Human molecular genetics

Published: November 28, 2012

Showing 1-12 of 14

Last Updated: 09/26/2026